Skip to content
Menu

Aktis Oncology, Inc. AKTS

Full chart Compare
Set alert

Price alert · AKTS

All alert types
16.15 USD -0.25 (-1.52%)

Regular-session close

16.15 0.00 0.00%

After hours · Nov 20, 4:01 PM ET

16.00 Day range 16.74
14.59 52-week range 32.23
YTD
-27.90%
1 year
-27.90%

Held by funds

61 US ETFs and mutual funds hold AKTS · largest positions

  1. VGHCX 0.07% of fund $28.47M
  2. VTI 0.00% of fund $16.62M
  3. IWM 0.02% of fund $11.87M
  4. NJM 0.01% of fund $9.31M
  5. XBI 0.08% of fund $8.77M
  6. FSSNX 0.02% of fund $6.02M
  7. VXF 0.01% of fund $5.71M
  8. SHSSX 0.08% of fund $5.19M
  9. VTWO 0.02% of fund $3.23M
  10. IWO 0.02% of fund $2.99M
  11. FSMAX 0.01% of fund $2.38M
  12. SCHA 0.01% of fund $2.20M
  13. NLO 0.01% of fund $1.68M
  14. NAJ 0.01% of fund $1.57M
  15. IWN 0.01% of fund $1.33M
  16. FSKAX 0.00% of fund $1.09M
  17. YALL 1.32% of fund $984.05K
  18. MDSKX 0.02% of fund $838.48K
  19. ITOT 0.00% of fund $563.60K
  20. FNCMX 0.00% of fund $556.26K

Ownership

  • Institutions 73.0%
  • Insiders 14.1%
  • Public and other holders 12.9%
Held by insiders 14.05%
Held by institutions 73.01%
Float held by institutions 84.94%
Institutions 164

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
MPM Bioimpact LLC9.00%4,835,87287.77MJun 29, 2026
EcoR1 Capital, LLC8.98%4,824,46987.56MJun 29, 2026
Blue Owl Capital Holdings LP5.71%3,070,21955.72MJun 29, 2026
Blackrock Inc.4.24%2,278,35841.35MJun 29, 2026
T. Rowe Price Investment Management, Inc.3.82%2,051,44737.23MJun 29, 2026
Wellington Management Group, LLP3.66%1,966,24435.69MJun 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund2.72%1,462,24426.54MJul 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.1.26%676,57712.28MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.09%585,13510.62MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.01%542,5939.85MAug 30, 2026
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund0.94%507,0009.20MJun 29, 2026
T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd.0.67%358,9476.51MJun 29, 2026

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs AKTS, and what each was last paid

Matthew Roden, President, CEO & DirectorAverage age 55

AKTS key executives
NameTitlePayAge
Matthew RodenPresident, CEO & Director$915K —
Akos CzibereChief Medical Officer$677K 48
Paul L. FeldmanChief Scientific Officer$642K 64
Shulamit Ron-BiggerChief Operating Officer$537K 45
Kyle D. KuvalankaChief Financial Officer— 58
Carlos RodriguezExecutive Director of Corporate Development— —
Todd FoleyCo-Founder & Chairman— 54
Patrick A. BaeuerleCo-Founder & Member of Scientific Advisory Board— 68
Tyler BenedumChief Technical Officer— 49
Dasa LipovsekVP & Head of Lead Discovery— —

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

AKTS insiders
InsiderRelationLatest transactionDateShares held
CZIBERE AKOS M.D.OfficerSaleSep 22, 20260
ECOR1 CAPITAL, L.L.C.UnknownPurchaseJan 11, 20260
FOLEY TODDDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseJan 11, 20260
GADICKE ANSBERT S.Beneficial Owner of more than 10% of a Class of SecurityPurchaseJan 11, 20260
HERRMANN KEN M.D.DirectorSaleJul 19, 20260
KIM HELEN SUSANDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseJan 11, 20260